Ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humansInterventional

Jim Beam Cumulative Irritation Patch Test

This study, called the "Jim Beam Cumulative Irritation Patch Test," is an early-stage medical trial. It's designed to see how people's skin reacts if a specific product (Jim Beam) is applied to it more than once. Researchers are specifically looking for any signs of skin irritation or redness. This type of study is called 'Human Pharmacology (Phase I)' and it's one of the first times this product is being tested on people. They are looking for healthy adult volunteers, aged 18 and over, both men and women, to take part. The main goal is to understand how safe the product is when it touches the skin, which is a key step before it could ever be used more widely.

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- First administration to humans

Sponsor

Reckitt Benckiser Healthcare (UK) Limited

Enrolment target

Start

11 Jun 2025

healthy volunteers

What is this study about?

This research study, called the "Jim Beam Cumulative Irritation Patch Test," is an important, early step to understand how a product might affect our skin. Imagine you're holding a new cream or a new drink. Before it can be used or sold, scientists need to make sure it doesn't harm your skin. This study is doing just that for something called Jim Beam.

In this trial, they are carefully putting a small amount of the product on a patch on your skin, likely more than once, to see if it causes any irritation, like redness or itching. This is a very common and safe way to check for skin reactions. Because it's a 'Phase 1' study, it means it's one of the very first times this specific test is being done on people, focusing purely on safety and how the body reacts.

The main reason this matters is to ensure that products are safe for people to use or be around. By understanding how skin reacts, researchers can identify any potential issues early on. This kind of work helps protect everyone and ensures that only safe products make it to the wider public.

Key takeaways

This study checks how skin reacts to repeated application of 'Jim Beam'.
It's an early-stage safety test on healthy adult volunteers.
The goal is to identify any skin irritation like redness or itching.
Participation involves skin patch application and clinic visits for checks.
You must be 18 or over and generally healthy to take part.
Contribution helps scientific understanding of product safety.

Who may be eligible?

This study is looking for volunteers who are generally healthy. This means you shouldn't have any major ongoing health problems, especially not any skin conditions that might make it hard to tell if the product is causing a reaction. Your doctor or the study team will ask you questions about your health to make sure you're a good fit.

To join, you need to be at least 18 years old. There is no upper age limit, so adults of any age, as long as they are healthy, can consider taking part. Both men and women are welcome to volunteer for this study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years of age or older?
Are you generally in good health?
Do you have any ongoing skin conditions, especially on the area where a patch might be placed?
Are you willing and able to attend multiple study visits if required?
Are you able to understand and give your agreement (consent) to participate?

Answer every question to see your result.

What does participation involve?

If you decide to take part, you'll be giving your permission for the researchers to apply a small patch containing the product, Jim Beam, to your skin. This will likely happen repeatedly over a period of time, as they are looking for 'cumulative irritation,' meaning how your skin reacts if it's exposed more than once.

You will probably need to visit the study clinic several times. During these visits, the study team will carefully check your skin where the patch was applied. They'll be looking for any signs of redness, itching, or other irritation. The total duration of your participation will depend on the study's plan, but these types of patch tests usually last for a few days to a couple of weeks. You won't be given any medication to take by mouth; the focus is just on the skin's reaction.

Potential risks and benefits

Taking part in this study could offer some benefits, such as contributing to scientific knowledge about product safety, which ultimately helps protect other people. You might also receive compensation for your time and travel. The main risk involves potential skin irritation (like redness, itching, or a rash) at the site where the product is applied. This irritation is usually mild and temporary. You have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

—
Unverified
Germany

Common questions

What is 'cumulative irritation'?

Cumulative irritation means they're looking to see how your skin reacts if a product is applied to it more than once, rather than just a single time. They want to see if repeated exposure causes irritation.

Will I have to take any medicine?

No, you won't be given any medicine to take by mouth. This study is only about applying a product to your skin and observing the reaction.

What does 'Human Pharmacology (Phase I)' mean?

It means this is a very early-stage trial, often the first time a product or test is being tried on people. The main goal is to check for safety and how the human body reacts.

Will this study affect my normal activities?

The study team will tell you if there are any activities you need to avoid, especially those that might affect your skin where the patch is placed, like swimming or showering in a certain way. Generally, these studies try to have minimal impact on your daily life.

Who is Jim Beam?

In this context, 'Jim Beam' refers to the name of the product or substance being tested, not a person. It's likely a specific ingredient or formulation being investigated for its skin effects.